Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Sales revenue	$ 0	$ 0
Cost of goods sold	0	0
Gross profit (loss)	0	0
Operating expenses	1,420,509	1,672,281
LOSS FROM OPERATIONS	(1,420,509)	(1,672,281)
OTHER (EXPENSE) INCOME
Interest expense	(218,973)	(178,652)
Loss on impairment of capitalized patent costs	(42,195)	(2,374,261)
Other income – collections in note receivable previously reserved for	320,000	100,000
Total other income/(expense)	58,832	(2,452,913)
LOSS BEFORE INCOME TAXES	(1,361,677)	(4,125,194)
Income tax expense	0	0
NET LOSS	(1,361,677)	(4,125,194)
Deemed dividend	(278,315)	0
Net loss attributable to common shareholders	$ (1,639,992)	$ (4,125,194)
Net loss per common share – basic and diluted (in dollars per share)	$ (0)	$ (0.01)
Weighted average common shares outstanding - basic and diluted (in shares)	396,728,680	357,721,189